 |
 |
||||||||
 |
|||||||||
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Attendees to the 1st Annual Update on Treatment Decisions for Gastrointestinal Diseases are able to attend the 3 complimentary satellite meetings available.
Please indicate your desire to attend any of the satellite meetings (via the web form on the right-hand side) so we can order the appropriate amount of food.
Please see the details below:
Fee: Complimentary Through this educational initiative, the Cleveland Clinic strives to produce significant knowledge gains for gastroenterologists and healthcare professionals. This knowledge will, in turn, improve the quality of care for the inflammatory bowel disease patient population. |
|
|
After completing the activity, the participant will be able to:
This activity is approved for AMA PRA Category 1 CreditTM Activity Director / Faculty: Bret Lashner, MD Should Patients with Cirrhosis be Restricted from Driving? Through this educational initiative, the Cleveland Clinic strives to produce significant knowledge gains for gastroenterologists, hepatologists, and healthcare professionals. This knowledge will, in turn, improve the quality of care for patients with liver disease and hepatic encephalopathy.
This activity is approved for AMA PRA Category 1 CreditTM Activity Director William D. Carey, MD Faculty: Kevin D. Mullen MD, FRCPI Matthew J. Donnelly, Esq. Emerging Therapies for Non-Surgical Treatment of Hepatocellular Carcinoma Fee: Complimentary Through this educational initiative, the Cleveland Clinic strives to produce significant knowledge gains for hepatologists, gastroenterologists, and other health care professionals. This knowledge will, in turn, improve the quality of care for the liver cancer disease patient population.
This activity is approved for AMA PRA Category 1 CreditTM Activity Directors Federico Aucejo, MD Nizar Zein, MD, FACG Faulty Richard Kim, MD Abraham Levitin, MD
|
||
